Publication year: 2020
Testbiotech comment on EFSA opinion regarding insect‐resistant and herbicide‐tolerant soybean DAS-81419-2 × DAS-44406-6
TESTBIOTECH Background 20 - 12 -2020
PDF icon Testbiotech_comment_soybean DAS-81419-2 x DAS-44406-6.pdf
Warum die Neue Gentechnik strikt reguliert werden muss
Fragen, Antworten und wissenschaftliche Hintergründe zu CRISPR & Co
PDF icon Fragen_Antworten_und_Fakten_CRISPR_und_Co.pdf
Technical background for a request for internal review against the decision of the EU Commission to renew the market authorisation for genetically engineered soybean A2704-12 (application EFSA-GMO-RX-009)
PDF icon Technical background for requesting internal review of the decision for renewal_soybean_A2704_12.pdf
Genetic engineering endangers the protection of species
Why the spread of genetically engineered organisms into natural populations has to be prevented
Christoph Then
PDF icon Genetic engineering endangers protection of species.pdf
Tabled overview on cross cutting gaps and deficiencies in current risk assessment as currently performed in the EU and Switzerland
Annex II to the summary report of the results from the RAGES project
PDF icon RAGES_Tabled overview gaps in current risk assessment.pdf
Gentechnik gefährdet den Artenschutz
Warum die Ausbreitung gentechnisch veränderter Organismen in den natürlichen Populationen verhindert werden muss
Christoph Then
PDF icon Gentechnik_Artenschutz_2020.pdf
Overview: the RAGES project
PDF icon RAGES_ Factsheet_Overview.pdf
Synergistic effects between Bt toxins and plant constituents (proteinase inhibitors, PI) multiply toxicity of GE plants (December 2020)
TESTBIOTECH Background 17 - 12 - 2020
PDF icon Testbiotech Background_ Bt plants and protease inhibitors.pdf
Why ‘New GE’ needs to be regulated
Frequently Asked Questions on ‘New Genetic Engineering’ and technical backgrounds for CRISPR & Co
PDF icon Frequently_asked_questions_about_CRISPR_and_Co.pdf
Testbiotech Background: Comment on EFSA draft document on risk assessment of plants developed with Type 1 (SDN-1) and Type 2 (SDN-2) site-directed nucleases and oligonucleotide directed mutagenesis (ODM) (May 2020)
PDF icon TBT_Background_on_SDN_Consultation.pdf